This article has Open Peer Review reports available.
A gallotannin-rich fraction from Caesalpinia spinosa (Molina) Kuntze displays cytotoxic activity and raises sensitivity to doxorubicin in a leukemia cell line
- Diana M Castañeda†1,
- Luis Miguel Pombo†2,
- Claudia Patricia Urueña1,
- John Fredy Hernandez1 and
- Susana Fiorentino1Email author
© Castañeda et al; licensee BioMed Central Ltd. 2012
Received: 27 September 2011
Accepted: 10 April 2012
Published: 10 April 2012
Enhancement of tumor cell sensitivity may help facilitate a reduction in drug dosage using conventional chemotherapies. Consequently, it is worthwhile to search for adjuvants with the potential of increasing chemotherapeutic drug effectiveness and improving patient quality of life. Natural products are a very good source of such adjuvants.
The biological activity of a fraction enriched in hydrolysable polyphenols (P2Et) obtained from Caesalpinia spinosa was evaluated using the hematopoietic cell line K562. This fraction was tested alone or in combination with the conventional chemotherapeutic drugs doxorubicin, vincristine, etoposide, camptothecin and taxol. The parameters evaluated were mitochondrial depolarization, caspase 3 activation, chromatin condensation and clonogenic activity.
We found that the P2Et fraction induced mitochondrial depolarization, activated caspase 3, induced chromatin condensation and decreased the clonogenic capacity of the K562 cell line. When the P2Et fraction was used in combination with chemotherapeutic drugs at sub-lethal concentrations, a fourfold reduction in doxorubicin inhibitory concentration 50 (IC50) was seen in the K562 cell line. This finding suggested that P2Et fraction activity is specific for the molecular target of doxorubicin.
Our results suggest that a natural fraction extracted from Caesalpinia spinosa in combination with conventional chemotherapy in combination with natural products on leukemia cells may increase therapeutic effectiveness in relation to leukemia.
Caesalpinia spinosa is a shrub commonly named dividivi. It is acknowledged to have antimicrobial and antioxidant activity, and is traditionally known for its antitumor activity . An ethanol extract from the fruit of C.spinosa has been proven to have antimicrobial activity against gram-positive and gram-negative bacteria, probably due to the presence of hydrolysable tannins in the fruits . Hydrolysable tannins are a group of gallic acid esters associated with polyols (glucose, glucitol, shikimic acid, quinic acid and quercitol, among others), where the galloyl groups can be further cross-linked by etherification or oxidation to form complex structures. The gallotannins (gallic acid esters) are the simplest hydrolysable tannins, were 1,2,3,4,6-penta-O-galloyl-β-D-glucose (pentagalloyl glucose [PGG]) is the prototype and central compound of the biosynthetic pathway . The presence of PGG, as well as gallotannins as mono, di or tri-galloylquinic acids, have been reported in Caesalpinia species corresponding to 40% to 60% of the fruit composition, depending upon their ecological habitat .
Gallic acid and its derivatives have proven selective antitumor activities, such as: reduction in biochemical markers associated with skin cancer ; cell death induction in several cancer cell lines, including leukemia [6, 7], murine myeloma  and squamous carcinoma . In addition, a beverage containing epigallocatechin gallate (EGCG) has been reported to promote tumor regression in patients with low-grade lymphomas . Galloylquinic derivatives, such as 4,5-di-O-galloylquinic acid, have shown moderate cytotoxicity against melanoma cells (RPMI-7951) but not in other cell lines . Extensive studies have been carried out on PGG and have demonstrated that this compound has a number biological activities related to cancer therapy and prevention, such as antiangiogenic, antiproliferative, anti-inflammatory and antioxidant . However, there are limited studies supporting the use of polyphenols in the treatment of hematological malignancies, and even fewer involving hydrolysable polyphenols. In the present study, taking into account that polyphenol antioxidant activity has been clearly implicated in the control of these malignancies , and that C.spinosa has a high content of polyphenols and is widely distributed in our country, we have evaluated the anti-tumor activity of C.spinosa pod extracts and complex fractions using the erythroleukemia cell line (K652) as a model of hematological malignancy.
C.spinosa pods were collected in Villa de Leyva, Boyacá, Colombia in March 2007 and identified by Luis Carlos Jiménez from the Colombian National Herbarium; voucher specimen number COL 523714.
Plant extraction and purification
Three kg of fresh pods from C.spinosa were dried under airflow in a solar oven at 35°C and ground down to obtain 1.8 kg of plant material. Subsequently the plant material was extracted with ethanol (96%, 10 L) in a recirculating percolator (twice per day) over a period of 10 days. The ethanol crude extract (80 g) was concentrated under vacuum, trapped on silica gel and excess humidity removed at 25°C. Afterwards, the ethanol extract was fractionated with the following solvents: petroleum ether (1.5 L); chloroform (2 L); ethyl acetate (2 L); ethanol (2 L) and water (2 L) (aqueous fraction). From the ethyl acetate fraction we obtained an abundant precipitate which we named (P2Et). This corresponded to 2.78% of the ethanol extract and a supernatant which we named (S2Et) corresponded to 1.11%. The P2Et, S2Et and aqueous fractions were selected for biological testing based on their cytotoxic activity. The extraction protocol was performed three times and the chromatographic profiles of the components were verified.
The quality control carried out on the P2Et fraction gave the following results: foreign matter less than 2%; total ash less than 8%; ash that was insoluble in hydrochloric acid less than 1%; no evidence of heavy metals and pesticides. These result met the British Herbal Pharmacopoeia quality parameters.
Fraction characterization was determined by means of standard phytochemical tests. In the total ethanol extract the presence of alkaloids or nitrogen compounds were not identified using Dragenddorff, Valser, Reineckate and Mayer's reagents. The Shinoda test (Mg in HCl) was positive suggesting the presence of flavanones, flavanonols, flavones, flavonols or isoflavones. Hydrogen peroxide evidenced the presence of naphthoquinones and/or anthraquinones. The presence of steroids was demonstrated using Liebermann Burchard reagent. Low concentrations of steroidal saponins and/or triterpenoids were detected using hemolysis and foam tests. In order to assess the presence of anthraquinone glycosides, Borntrager's reaction (treatment with ammonia solution) was used. The presence of tannins was verified using ferric chloride solution, gelatin and lead acetate . P2Et, S2Et and aqueous fractions exhibited the presence of leucoanthocyanidins, the absence of quinones and a significant tannin content, especially in P2Et fraction.
Thin layer chromatography (TLC)
Chromatographic analysis was carried out on TLC aluminum sheets (10 × 5 cm) (Merck) silica gel 60 F 254. Three solvent systems were used: Petroleum ether - ethyl acetate - formic acid (40:60:1); chloroform - ethyl acetate - acetic acid (50:50:1); and toluene - acetonitrile - formic acid (70:30:1). After basic hydrolysis, the P2Et and S2Et fractions were dissolved in methanol (1%) and detected using UV (254 nm), FeCl3 (10%) and vanillin-sulfuric acid (VS)/110°C. Gallic acid was used as a positive control.
HPLC - PDA-MS
HPLC analysis was carried out in an Alliance 2795 (Waters®, UK) with a PDA detector (996). A Sunfire (Waters) column C18 - 2.1 × 150 mm × 5 μm was used, with a flow rate of 0.25 ml/min and a linear gradient from 95% solvent A (H2O + 1%CH3COOH) and 5% solvent B (CH3CN) to 60% in solvent A and 40% in solvent B, over a period of 25 min. The mass spectrum (MS) analysis was carried out using a LCT (Micromass®, UK) mass spectrometer with an ESI source. The percentage relative abundance was determined using quercetin as an internal standard (0.0625 μg/μl). Runs were performed in triplicate.
Tumor cell line and normal cells
The cell lines used as cancer cells were K562, a human erythroleukemia and MCF7, a human breast adenocarcinoma, from the American Type Culture Collection (ATCC); and the cell lines used as normal cells were human peripheral blood mononuclear cells (PBMC) and human fibroblasts obtained from normal healthy donors after informed consent was given. This project was approved by the ethics committee (founded in 2002) of the Science Faculty at a meeting on August 21, 2007. The culture conditions under which the cell lines were maintained have already been reported .
In vitro cytotoxicity assays
The cytotoxic effects of the fractions and conventional chemotherapeutic drugs (doxorubicin, etoposide, vincristine and taxol) were evaluated using normal and tumor cells by means of trypan blue and the methylthiazol tetrazolium (MTT) assay, as previously reported . The P2Et fraction was dissolve in ethanol and the corresponding vehicle was used as a negative control.
Measurement of mitochondrial membrane potential
The cells were treated with different concentrations of the P2Et fraction or valinomycin (positive control, 0.1 μg/ml) for 4, 8 and 12 h for K562 cells, and for 6, 12 and 24 h for MCF7 cells. The mitochondrial membrane potential (MMP) was measured using JC-1 dye, as previously described .
Annexin V assay
Phosphatidylserine (PS) externalization was assessed by flow cytometry using Annexin V-FITC (Molecular Probes, Invitrogen Corp, Carlsbad, CA, USA)/PI (Sigma, Saint Louis, MO, USA). K562 and MCF7 cells (3 × 105) were treated with doxorubicin, ethanol or the P2Et fraction for 48 h. After treatment, cells were suspended in Annexin buffer (Hepes 100 mM, NaCl 140 mM, CaCl2 2.5 mM) and incubated with Annexin V-FITC for 8 min at room temperature. Then the cells were incubated with PI for 2 min at 4°C, acquired on a FACSAria I (Becton Dickinson, New Jersey, USA) and analyzed with FlowJo software (Tree Star Inc., Ashland, USA). Results are expressed as the mean ± SE of three independent experiments.
Caspase 3 assays
Caspase 3 activity was estimated using the caspase 3 colorimetric assay kit, which detects enzyme activity based on the cleavage of Asp-Glu-Val-Asp (DEVD)-pNA (R&D Systems Inc., Minneapolis, MN, USA). Briefly, cells (2 × 105 cells/ml) were cultured using different concentrations of the P2Et fraction and doxorubicin (positive control) or ethanol (negative control) for 48 h. After the cells were ice lysed for 10 min the enzyme activity was measure on 96-well flat-bottom microplates with 50 μl of supernatant. The supernatant was prepared by centrifuging at 10,000 × g for 1 min (100-200 μg of total protein), and then adding 50 μl of reaction buffer supplemented with 10 μl of DTT and 5 μl of caspase 3 colorimetric substrate DEVD-pNA. Next cells were incubated for 1 ± 2 h at 37°C and caspase-3 activity was measured at 405 nm on a spectrophotometer (Multiskan Labsystem). The increase in caspase 3 activity was calculated relative to the absorbance value of the negative control.
DNA fragmentation and cell cycle analysis
DAPI (4',6-diamidino-2-phenylindole, Sigma) stained cells were monitored under a microscope as previously described . Slides were mounted using prolong anti-fade kit (Molecular Probes, Eugene, Oregon, USA) and cells were analyzed under a fluorescence microscope (Olympus, Japan). Cell cycle analysis was undertaken as previously reported .
The clonogenic assays were performed as previously described . Briefly, K562 human cells (2.5 × 105 cells/well) were plated (96-well plate) and treated with the P2Et fraction at 40 and 20 μg/ml, or with 15 and 6 μg/ml etoposide, or 0.2% ethanol (in PBS) and incubated for 24 h under a humidified environment at 37°C and 5% CO2. After treatment cells were re-plated onto 0.5% agar dishes (60 mm, 20,000 cells/dish), incubated for 14 days (37°C and 5% CO2) and stained with violet crystal (0.4% in ethanol). Cell colonies with more than 50 cells were counted. Treatments were performed in triplicate, and results expressed as mean ± SE.
P2Et fraction adjuvant activity
P2Et fraction adjuvant activity was assessed using K562 and MCF7 cells in combination with the well-known cancer treatment drugs doxorubicin, vincristine, taxol and camptothecin. Cell viability was evaluated by means of the MTT assay. K562 and MCF7 cells (5 × 103 cells/well) were seeded in 96-well plates and treated for 6 h with sublethal concentrations of the P2Et fraction (1.6 μg/ml, 27 fold less than the IC50 value for K562 cells and 15.5 μg/ml for MCF7 cells); washed and incubated in fresh medium with each drug for 48 h at 37°C in humid atmosphere and 5% CO2. Sublethal concentrations of the chemotherapeutic drugs had been previously determined by MTT assay. Results are expressed as cell viability percentage relative to the control (100 × Treatment OD/Negative control OD).
Data is presented as the mean ± SE. The data were analyzed by one- and two-way ANOVA and differences between control and treated groups were determined using the Bonferroni and Tukey tests. Differences were considered significant for p < 0.05 and were determined using the GraphPad prism 5.0 software.
Results and discussion
TLC and HPLC-PDA-MS analyses
Compounds in the P2Et fraction.
Relative abundance* (%)
Morphological and cell viability changes in the K562 tumor cell line induced by fractions derived from Caesalpinia spinosa
In order to confirm cell viability the activity of mitochondria dehydrogenase was estimated using the MTT assay. The aqueous fraction induced cytotoxicity at a concentration of 62.5 μg/ml, while the S2Et and P2Et fractions induced cytotoxicity at concentrations of 31.2 and 15.6 μg/ml, respectively (Figure 2C). The P2Et fraction displayed significant cytotoxic activity in a dose-dependent manner. This finding was in agreement with those reported in previous studies on leukemia cells using chemically related P2Et tannins. Alkyl gallates and gallamides have been shown to exhibit cytotoxic activity with regard to murine lymphocyte leukemia cells (L1210) , and an acetone derived gallotannin-enriched fraction extracted from Eugenia jambos species was found to have a cytotoxic effect on promyelocytic leukemia HL-60 cells . The biological activity of tannins has been widely documented [6, 17], but reports related to C. spinosa anti-tumoral activity are scarce. Gali-Muhtasib et al. found that hydrolysable tannins extracted from the fruit of C. spinosa decreased the level of skin cancer biochemical markers. In addition, there are reports describing anti-inflammatory and anti-microbial activity of tannins .
IC50 values of C.spinosa fractions and drugs in tumor cell lines and normal cells (gingival fibroblasts and PBMC) estimated using the MTT assay. *Concentration (μg/ml) ± SE
44.50* ± 4.05
64.30* ± 1.00
15.60* ± 0.31
0.24* ± 0.14
5.80* ± 0.40
2023* ± 0.50
1.14* ± 0.15
1.07* ± 0.28
0.07* ± 2.40
0.18* ± 2.00
14.10* ± 3.70
Induction of MMP loss, caspase 3 activation and DNA fragmentation in the K562 cell line by the P2Et fraction
Loss of MMP induced by the P2Et fraction can be seen as an early apoptotic event that lasts for 12 h. These results correlated with previously described activity for alkyl gallates and gallamides having 8 to 12 carbon chains [6, 18]. In addition, the P2Et fraction induced caspase 3 activation and DNA fragmentation, suggesting that after MMP loss, apoptotic cell death may be ongoing. However, since evidence of PS externalization was not found (Figure 3D), the decrease in long-term viability might be mediated by other cell death mechanisms.
Effect of the P2Et fraction on tumor cell clonogenic capacity
Adjuvant activity of the P2Et fraction
The use of natural products as adjuvants in antitumor therapy has been previously addressed; indeed, EGCG, a condensate tannin present in green tea, has been shown to sensitize cancer cells to taxol treatment in a breast cancer model . Also, it has been reported that EGCG (at low doses) and epicatechin gallate are not cytotoxic to a chemoresistant hepatocellular carcinoma, but in combination with doxorubicin, tumor cells were sensitized and a decrease in tumor size was seen in vivo using a doxorubicin-resistant liver cancer model . The C. spinosa fraction that was enriched in gallotannins not only exhibited cytotoxic activity, but also activity associated with conventional anti-cancer drugs, demonstrating once again the efficiency of natural products as potential sources of adjuvants that can be used in antitumor therapy. Herein, we described a C.spinosa derived fraction, P2Et, that was relatively easy to produce and which offered high yields in the extraction procedures; and preliminary cytotoxicity studies suggest that it can be used at very low dosages. In studies using several other cell lines (data not shown) a wide range of activities may be foreseen. Currently, the in vivo antitumor activity of the P2Et fraction is being evaluated and chemical characterization is being completed so that the molecular interactions may be scrutinized; and so that the cell death mechanism and the sensitization exerted by this fraction can be elucidated.
Our results suggest that the therapeutic efficacy of conventional chemotherapeutic drugs when combined with a blend of natural polyphenols may be increased in relation to leukemia or breast cancer cells. However, the molecular mechanisms underlying this activity have yet to be explained and are currently under study at our laboratory.
The authors thank the Science Faculty of the Pontificia Universidad Javeriana, Fundación Universitaria Juan N. Corpas for their support and the Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología "Francisco Jose de Caldas" (COLCIENCIAS) Bogotá, Colombia, for financial support.
- Chanwitheesuk A, Teerawutgulrag A, Kilburn J, Rakariyatham N: Antimicrobial gallic acid from Caesalpinia mimosoides lamk. Food Chem. 2007, 100: 1044-1048. 10.1016/j.foodchem.2005.11.008.View ArticleGoogle Scholar
- Kloucek P, Polesny Z, Svobodova B, Vlkova E, Kokoska L: Antibacterial screening of some Peruvian medicinal plants used in Calleria District. J Ethnopharmacol. 2005, 99 (2): 309-312. 10.1016/j.jep.2005.01.062.View ArticlePubMedGoogle Scholar
- Zhang J, Li L, Kim SH, Hagerman AE, Lu J: Anti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose. Pharm Res. 2009, 26 (9): 2066-2080. 10.1007/s11095-009-9932-0.View ArticlePubMedPubMed CentralGoogle Scholar
- Clifford MN, Stoupi S, Kuhnert N: Profiling and characterization by LC-MSn of the galloylquinic acids of green tea, tara tannin, and tannic acid. J Agric Food Chem. 2007, 55 (8): 2797-2807. 10.1021/jf063533l.View ArticlePubMedGoogle Scholar
- Gali-Muhtasib HU, Yamout SZ, Sidani MM: Tannins protect against skin tumor promotion induced by ultraviolet-B radiation in hairless mice. Nutr Canc. 2000, 37 (1): 73-77. 10.1207/S15327914NC3701_9.View ArticleGoogle Scholar
- Locatelli C, Rosso R, Santos-Silva MC, de Souza CA, Licinio MA, Leal P, Bazzo ML, Yunes RA, Creczynski-Pasa TB: Ester derivatives of gallic acid with potential toxicity toward L1210 leukemia cells. Bioorg Med Chem. 2008, 16 (7): 3791-3799. 10.1016/j.bmc.2008.01.049.View ArticlePubMedGoogle Scholar
- Inoue M, Suzuki R, Koide T, Sakaguchi N, Ogihara Y, Yabu Y: Antioxidant, gallic acid, induces apoptosis in HL-60RG cells. Biochem Biophys Res Commun. 1994, 204 (2): 898-904. 10.1006/bbrc.1994.2544.View ArticlePubMedGoogle Scholar
- Pellegrina CD, Padovani G, Mainente F, Zoccatelli G, Bissoli G, Mosconi S, Veneri G, Peruffo A, Andrighetto G, Rizzi C: Anti-tumour potential of a gallic acid-containing phenolic fraction from Oenothera biennis. Cancer Lett. 2005, 226 (1): 17-25. 10.1016/j.canlet.2004.11.033.View ArticlePubMedGoogle Scholar
- Chia YC, Rajbanshi R, Calhoun C, Chiu RH: Anti-neoplastic effects of gallic acid, a major component of Toona sinensis leaf extract, on oral squamous carcinoma cells. Molecules. 2010, 15 (11): 8377-8389. 10.3390/molecules15118377.View ArticlePubMedGoogle Scholar
- Shanafelt TD, Lee YK, Call TG, Nowakowski GS, Dingli D, Zent CS, Kay NE: Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies. Leuk Res. 2006, 30 (6): 707-712. 10.1016/j.leukres.2005.10.020.View ArticlePubMedGoogle Scholar
- Kashiwada Y, Nonaka G, Nishioka I, Chang JJ, Lee KH: Antitumor agents, 129. Tannins and related compounds as selective cytotoxic agents. J Nat Prod. 1992, 55 (8): 1033-1043. 10.1021/np50086a002.View ArticlePubMedGoogle Scholar
- Kelkel M, Jacob C, Dicato M, Diederich M: Potential of the dietary antioxidants resveratrol and curcumin in prevention and treatment of hematologic malignancies. Molecules. 2010, 15 (10): 7035-7074. 10.3390/molecules15107035.View ArticlePubMedGoogle Scholar
- Chaudhari M, Mengi S: Evaluation of phytoconstituents of Terminalia arjuna for wound healing activity in rats. Phytother Res. 2006, 20 (9): 799-805. 10.1002/ptr.1857.View ArticlePubMedGoogle Scholar
- Uruena C, Cifuentes C, Castaneda D, Arango A, Kaur P, Asea A, Fiorentino S: Petiveria alliacea extracts uses multiple mechanisms to inhibit growth of human and mouse tumoral cells. BMC Compl Alternative Med. 2008, 8: 60-10.1186/1472-6882-8-60.View ArticleGoogle Scholar
- Sharma OP, Bhat TK, Singh B: Thin-layer chromatography of gallic acid, methyl gallate, pyrogallol, phloroglucinol, catechol, resorcinol, hydroquinone, catechin, epicatechin, cinnamic acid, p-coumaric acid, ferulic acid and tannic acid. J Chrom A. 1998, 822: 167-171. 10.1016/S0021-9673(98)00490-7.View ArticleGoogle Scholar
- Yang LL, Lee CY, Yen KY: Induction of apoptosis by hydrolyzable tannins from Eugenia jambos L. on human leukemia cells. Cancer Lett. 2000, 157 (1): 65-75. 10.1016/S0304-3835(00)00477-8.View ArticlePubMedGoogle Scholar
- Kim NS, Jeong SI, Hwang BS, Lee YE, Kang SH, Lee HC, Oh CH: Gallic acid inhibits cell viability and induces apoptosis in human monocytic cell line U937. J Med Food. 2011, 14 (3): 240-246. 10.1089/jmf.2010.1160.View ArticlePubMedGoogle Scholar
- Serrano A, Palacios C, Roy G, Cespon C, Villar ML, Nocito M, Gonzalez-Porque P: Derivatives of gallic acid induce apoptosis in tumoral cell lines and inhibit lymphocyte proliferation. Arch Biochem Biophys. 1998, 350 (1): 49-54. 10.1006/abbi.1997.0474.View ArticlePubMedGoogle Scholar
- Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR: Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009, 16 (1): 3-11. 10.1038/cdd.2008.150.View ArticlePubMedGoogle Scholar
- Chen R, Gandhi V, Plunkett W: A sequential blockade strategy for the design of combination therapies to overcome oncogene addiction in chronic myelogenous leukemia. Cancer Res. 2006, 66 (22): 10959-10966. 10.1158/0008-5472.CAN-06-1216.View ArticlePubMedGoogle Scholar
- Pan MH, Lin JH, Lin-Shiau SY, Lin JK: Induction of apoptosis by penta-O-galloyl-beta-D-glucose through activation of caspase-3 in human leukemia HL-60 cells. Eur J Pharmacol. 1999, 381 (2-3): 171-183. 10.1016/S0014-2999(99)00549-X.View ArticlePubMedGoogle Scholar
- Luo T, Wang J, Yin Y, Hua H, Jing J, Sun X, Li M, Zhang Y, Jiang Y: (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma. Breast Cancer Res. 2010, 12 (1): R8-10.1186/bcr2473.View ArticlePubMedPubMed CentralGoogle Scholar
- Liang G, Tang A, Lin X, Li L, Zhang S, Huang Z, Tang H, Li QQ: Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol. 2010, 37 (1): 111-123.PubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/12/38/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.